Delft reports rise in medical orders:
This article was originally published in Clinica
Executive Summary
Dutch instruments manufacturer Delft has reported that its order intake in the medical sector rose substantially in the first half, mainly due to demand for radiotherapy and diagnostics products. In this period revenues declined 5% to Fl 188.2 million ($113 million). Delft blames the lower sales on a disposal, but also says that sales in the medical sector were slightly lower. Net profit rose to Fl 3.1 million compared with Fl 1.5 million last year.